Label Comprehension Study
Through reactions to scenarios, consumers across all cohorts demonstrated a strong understanding …
- That this product should not be used in situations where serious symptoms are present – General Warnings (75-96% Correct/Acceptable Responses)
- Of who can and cannot use Claritin® (75-99% Correct/Acceptable)
- Of conditions under which one must ask a doctor before use (94-100% Correct/Acceptable)
- Of conditions under which the product should be used (95-100% Correct/Acceptable)